Johnson & Johnson's $16.6B acquisition of Abiomed was the largest, followed by Stryker's acquisition of Vocera and Thermo Fisher's acquisition of the Binding Site.

(Please use a modern browser to see the interactive version of this visualization)

Note: Premium over previous day's close was calculated by comparing the price per share to the seller's closing price the day before the acquisition was announced.

Table: Elise Reuter Source: EY Get the data